CDC157: A Potential Drug Target Or Biomarker (G550631)

Target Name: CCDC157

NCBI ID: G550631

CCDC157

CDC157: A Potential Drug Target Or Biomarker

CCDC157 (CC157_HUMAN), a protein that is expressed in various tissues of the human body, including the brain, has been identified as a potential drug target or biomarker. The study of CCDC157 and its potential therapeutic applications has generated a lot of interest in recent years.

CDC157 is a member of the superfamily of evolutionarily conserved cytoskeleton-associated proteins (CAPs), which are involved in various cellular processes such as cell division, cytoskeletal organization, and intracellular signaling. It is a 21-kDa protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidneys.

One of the unique features of CCDC157 is its ability to interact with various signaling molecules, including tyrosine, which is a well-known protein that is involved in intracellular signaling. This interaction between CCDC157 and tyrosine has led to the hypothesis that CCDC157 could be a drug target or biomarker for various diseases.

In addition to its potential role as a drug target or biomarker, CCDC157 has also been shown to play a role in various biological processes that are important for human health. For example, CCDC157 has been shown to be involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs.

CDC157 has also been shown to be involved in the regulation of cellular signaling pathways that are important for various cellular processes, including cell growth, differentiation, and survival. This suggests that CCDC157 may be a useful target for drugs that are designed to modulate these signaling pathways and improve cellular health.

The potential therapeutic applications of CCDC157 are vast and varied. For example, CCDC157 has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. It is possible that CCDC157 could be a useful target for drugs that are designed to prevent or treat these diseases.

In addition to its potential therapeutic applications, CCDC157 has also been shown to be a useful biomarker for various diseases. For example, CCDC157 has been shown to be involved in the regulation of cellular signaling pathways that are important for the development and progression of cancer, and it is possible that it could be used as a biomarker for cancer diagnosis or treatment.

The study of CCDC157 and its potential therapeutic applications is an active area of research, and there is a lot of interest in the study of its role in various biological processes. Further studies are needed to fully understand the role of CCDC157 in these processes and to develop effective treatments based on its potential as a drug target or biomarker.

Protein Name: Coiled-coil Domain Containing 157

The "CCDC157 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC157 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets